1
Donald J Eaton, Thomas R Tice, David B Downie, Patrick A Arensdorf, Rodney Brenneman, Danielle L Biggs: Device and methods for treating paranasal sinus conditions. Intersect ENT, Morrison & Foerster, September 27, 2011: US08025635 (66 worldwide citation)

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus ...


2
Donald J Eaton, Thomas R Tice, David B Downie, Patrick A Arensdorf, Rodney Brenneman, Danielle L Biggs: Device and methods for treating paranasal sinus conditions. Intersect ENT, Morrison & Foerster, December 25, 2012: US08337454 (44 worldwide citation)

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus ...


3
Patrick A Arensdorf, Danielle L Biggs, Rodney Brenneman, David B Downie, Donald J Eaton, Thomas R Tice: Devices and methods for delivering active agents to the osteomeatal complex. Intersect ENT, Morrison & Foerster, September 17, 2013: US08535707 (31 worldwide citation)

Described here are devices, methods, and kits for treating sinusitis and related respiratory conditions by locally delivering active agents to the osteomeatal complex over a sustained period of time. The devices may be passively fixed within the osteomeatal complex and/or include one or more feature ...


4
Donald J Eaton, Thomas R Tice, David B Downie, Patrick A Arensdorf, Rodney A Brenneman, Danielle L Biggs: Device and methods for treating paranasal sinus conditions. Intersect ENT, Morrison & Foerster, June 3, 2014: US08740839 (23 worldwide citation)

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus ...


5
Donald J Eaton, Thomas R Tice, David B Downie, Patrick A Arensdorf, Rodney Brenneman, Danielle L Biggs: Device and methods for treating paranasal sinus conditions. Intersect ENT, Morrison & Foerster, October 14, 2014: US08858974 (12 worldwide citation)

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus ...


6
Michael S Urdea, Michael P McKenna, Patrick A Arensdorf: Diabetes-related biomarkers and methods of use thereof. Tethys Bioscience, Marshall Gerstein & Borun, May 25, 2010: US07723050 (11 worldwide citation)

The invention describes biomarkers which can be used to predict the likelihood that an individual will develop Diabetes. The biomarkers can also be used to screen large groups in order to identify individuals at risk of developing Diabetes.


7
Michael S Urdea, Michael P McKenna, Patrick A Arensdorf: Diabetes-related biomarkers and methods of use thereof. Tethys Bioscience, Marshall Gerstein & Borun, February 21, 2012: US08119358 (9 worldwide citation)

The invention describes biomarkers which can be used to predict the likelihood that an individual will develop Diabetes. The biomarkers can also be used to screen large groups in order to identify individuals at risk of developing Diabetes.


8
Michael S Urdea, Michael P McKenna, Patrick A Arensdorf: Diabetes-related biomarkers and methods of use thereof. Tethys Bioscience, Marshall Gerstein & Borun, April 2, 2013: US08409816 (6 worldwide citation)

The invention describes biomarkers which can be used to predict the likelihood that an individual will develop Diabetes. The biomarkers can also be used to screen large groups in order to identify individuals at risk of developing Diabetes.


9
Donald J Eaton, Thomas R Tice, David B Downie, Patrick A Arensdorf, Rodney A Brenneman, Danielle L Biggs: Device and methods for treating paranasal sinus conditions. Intersect ENT, Cooley, March 7, 2017: US09585681

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus ...


10
Michael S Urdea, Michael P McKenna, Patrick A Arensdorf: Diabetes-related biomarkers and methods of use thereof. Health Diagnostic Laboratory, Finnegan Henderson Farabow Garrett & Dunner, May 19, 2015: US09034585

The invention describes biomarkers which can be used to predict the likelihood that an individual will develop Diabetes. The biomarkers can also be used to screen large groups in order to identify individuals at risk of developing Diabetes.